The microencapsulation of cells has shown promise as a therapeutic vehicle for the treatment of a wide variety of diseases. While alginate microcapsules provide an ideal cell encapsulation material, polycations coatings are commonly employed to enhance stability and impart permselectivity. In this study, functionalized hyperbranched alginate and dendrimer polymers were used to generate discreet nanoscale coatings onto alginate microbeads via covalent layer-by-layer assembly. The bioorthogonal Staudinger ligation scheme was used to chemoselectively crosslink azide functionalized hyperbranched alginate (alginate-hN 3 ) to methyl-2-diphenylphosphinoterephthalate (MDT) linked PAMAM dendrimer (PAMAM-MDT). Covalent layer-by-layer deposition of PAMAM-MDT/alginate-hN 3 coatings onto alginate microbeads resulted in highly stable coatings, even after the inner alginate gel was liquefied to form microcapsules. The permselectivity of the coated microcapsules could be manipulated via the charge density of the PAMAM, the number of layers deposited, and the length of the functional arms. The cytocompatibility of the resulting PAMAM-MDT/alginate-hN 3 coating was evaluated using a beta cell line, with no significant detrimental response observed. The biocompatibility of the coatings in vivo was also found comparable to uncoated alginate beads. The remarkable stability and versatile nature of these coatings provides an appealing option for bioencapsulation and the release of therapeutic agents.
INTRODUCTION
The transplantation of cells to deliver therapeutic agents, such as trophic factors, hormones, antigens, and proteins, is an extensively investigated approach with broad clinical applications. [1] [2] [3] [4] [5] [6] [7] [8] [9] When used as a delivery agent, encapsulation of these cells within semipermeable biomaterials provides an attractive approach to protect the foreign cells from the host immune system, where the encapsulation biomaterial permits the diffusion of the therapeutic agent into the surrounding milieu but prevents direct host cell infiltration. Of particular interest to the field is the use of encapsulated insulin secreting cells for the treatment of Type 1 Diabetes Mellitus (TIDM).
Multiple studies have demonstrated the reversal of diabetes upon the transplantation of encapsulated pancreatic islets, exhibiting the promise of this approach for stabilizing blood glucose levels in the absence of anti-rejection therapy. [10] [11] [12] [13] Alginate is one of the most widely used biomaterials for cellular encapsulation. [14] [15] [16] [17] Alginate is a collective term for a family of polysaccharides derived from brown algae. Alginate chains are linear binary co-polymers of β-D-mannuronic (M) and α-L-guluronic (G) acids, with a variation of sequential arrangement and composition depending on their source. 18, 19 The gelation of alginate microbeads is commonly achieved via exposure to divalent cations (typically Ca 2+ or Ba 2+ ); however, the resulting alginate hydrogel lacks the long-term stability to withstand the mechanical and chemical strains associated with implantation, where microbead degradation and rupture commonly develops due to the slow exchange of cations with sodium ions under physiological conditions. 20, 21 Stabilization of alginate microbeads is commonly achieved via the assembly of nano to microscale polyelectrolyte coatings on the outer alginate surface. These are assembled through layer-by-layer deposition of polymers of alternating charges, where the first layer deposited is a polycation, due to the anionic nature of alginate. Polycations typically used for alginate coatings are poly-l-lysine and poly-L-ornithine. 22, 23 Following deposition of the polycation layer, a final layer of alginate is then deposited. Although assembled in a layer-bylayer manner, it has been determined that these coatings complex to form a single polycation/polyanion shell. 16, 24, 25 As such, polycations contained within the coatings are exposed on the outer surface of the capsule. This was precipitated with 40 mL acetone, dissolved in 4 mL of 50 mM NaCl, precipitated with 8 mL acetone, and dried under reduced pressure. Next, 50 mg of hyperbranched alginate and 50 mg of H 2 N-PEG-N 3 (M w 372 g/mol) were reacted with 125 mg EDC in 5 mL purified water containing 5 mg NHS, 30 mg MES, and either 0 or 2 mg of fluorescein-5-thiosemicarbazide. After 20 min, 30 µL of 5 M NaOH was added at 1 µL/min. Hyperbranched alginate-azide was precipitated with 20 mL acetone, dissolved/precipitated twice in 3 mL of 50 mM NaCl/15 mL acetone, dried under reduced pressure, purified by dialysis (10 kDa MWCO, against 500 mL water replaced every 20 min for 2 h, 10 µL NaOH and 200 µL 1 M NaCl were added to the alginate solution during the first hour every 20 min), filter-sterilized, and freeze-dried.
For the functionalization of poly(amidoamine) (PAMAM) dendrimers, generation 5 PAMAM (1 mL of 5 % in CH 3 OH, 39.85 mg) was reacted with 14 mg of 4-pentafluorophenyl ester of 1-methyl-2-(diphenylphosphino)terephthalic acid in 0.5 mL anhydrous dichloromethane (DCM, injected drop-wise) for 30 min under argon atmosphere (PAMAM 15/0). For PAMAM 15/20 or 15/40, 25 µL of triethylamine in 0.5 mL DCM was injected followed by 4 or 8 mg (respectively) of glutaric anhydride in 0.5 mL DCM (injected drop-wise). After 30 min, 20 µL glacial acetic acid was added, the product precipitated with 10 mL diethyl ether, dissolved/suspended in 1 mL of 50 % v/v DCM in methanol, precipitated with 10 mL diethyl ether, dried under reduced pressure, dissolved in 2 mL water with 20 µL glacial acetic acid, purified by dialysis (10 kDa MWCO, against 500 mL water replaced every 20 min for 2 h). 100 µL of 1 M NaCl was added to the alginate solution every 20 min for the first hour, filter-sterilized, and freeze-dried. ATR-FT-IR spectra characterized MDT group (1719, 746, and 697 cm -1 ) and amide bonding (1637 and 1539 cm -1 ), while the degree of functionalization was determined via NMR peak integration ratio between aromatic ( 6.5-8.2 ppm) or GA ( 1.83 ppm) against PAMAM ( 2.07-3.66 ppm) protons. Characterization data of selected MDT and GA functionalized PAMAM dendrimers are summarized in Table 1 . Of note, the surface net charge listed for the specific dendrimer assumes every primary amino or carboxylate group is charged, thus the true net charge depends on pH of the solution gelation solution) and manual force applied to the syringe. The beads were exposed to the gelation solution for 10 min to form a stable hydrogel. The barium solution was aspirated and the beads were then rinsed with PBS four times to remove excess barium. For coating and permselectivity studies, resulting microbead diameters averaged 757 ± 35 µm (n = 19). Microbeads were stored in PBS prior to bead swelling and/or chelation assays.
For microbeads containing cells, MIN6 cells were used. MIN6 cells (subclone C3, courtesy of Dr. Valerie Lilla and Alejandra Tomas) 44 immediately extruded through the air flow bead generator to form microbeads, as described above. Following an 8 min exposure to the barium gelation solution and PBS rinse (4 times), the cell-containing microbeads were washed in culture media described above. Beads were subsequently coated in PAMAM/alginate microbeads prior to culture in non-cell culture treated plates in a humidified 37 ⁰C, 5 % CO 2 / 95 % air incubator for 48 h prior to assessment. Resulting microbead diameters for averaged 815 ± 34 µm (n = 24).
Coating of alginate or alginate-azide microbeads with PAMAM/alginate or PLL/alginate
For layer-by-layer assembly of PAMAM and alginate-hN 3 onto the alginate microbeads, microbeads were first incubated in the PAMAM polymer solution (3 mg/mL in PBS buffer) for 10 min at 37 ˚C, following by rinsing (3x) with PBS. Subsequently, a layer of alginate-hN 3 was added via incubation of PAMAM coated bead with alginate-hN 3 polymer solution (3 mg/mL in PBS buffer) for 10 min at 37 ˚C, following by rinsing (3x) with PBS. This process was repeated until the desired number of layers was achieved. A plastic disposable Pasteur pipet was frequently utilized to stir and separate the microbeads to prevent aggregation. The polymer solution was supplemented with glucose (3 mg/dL) when coating microbeads containing MIN6 cells.
Microbeads coated with poly-L-lysine and standard alginate (PLL/Alg) served as the control group. To generate the PLL coating, microbeads were incubated in 0.05% (wt/v) of poly-L-lysine (MW 30,000-70,000, Sigma Cat #P2636) in PBS buffer for 6 min at room temperature. Excess PLL was rinsed away with multiple washes with PBS buffer. Microbeads were subsequently incubated in 0.15% of standard alginate (UP MVG) for 4 min at room temperature, followed by extensive rinsing in PBS.
Cell-free coated microbeads were stored at 37 ⁰C in PBS. For cell loaded, microbeads were cultured as described above. For formation of microcapsules, coated microbeads were treated with 50 mM EDTA solution in MOPS buffer (1x, pH 7.4) for 15 min in order to chelate barium ions from the alginate core. The resulting capsules were rinsed three times with PBS (1x, pH 7.4) for 5 min. Following rinsing, microbeads were assessed for swelling.
Swelling and Permeability of Capsules
For swelling testing, the diameter of multiple (at least 4) coated beads in PBS was measured before and 1 h after EDTA treatment utilizing the SZX7 stereo microscope (Olympus). Degree of swelling was calculated from the ratio of capsule diameter over bead diameter.
Permeability testing was conducted on coatings following EDTA treatment, to minimize the contribution of the alginate hydrogel on permselectivity. For permeability testing, coated alginate or alginate-N 3 microcapsules The permselectivity or molecular weight cut-off of the capsules was experimentally identified when the % permeability for a particular dextran molecular weight was < 10%. The corresponding hydrodynamic radius of the dextran was theoretically determined using the following published formula 45 :
where R h is the hydrodynamic radius of the dextran in nm and MW is the molecular weight in g/mol.
Atomic Force Microscopy
A commercial atomic force microscope (MFP-3D-BIO, Asylum Research) was used to obtain high-magnification images of the polymer coatings. In order to hold the sample steady during AFM imaging, the microbeads were hyperbranched; a portion of carboxylate groups of alginate were simply functionalized with linear H 2 N-PEG-N 3 .
Both microbeads were generated via ionic gelation. Resulting microbeads were coated with layers of PAMAM and alginate, functionalized with methyl-2-diphenylphosphino-terephthalate (MDT) and azide, respectively, via stepwise incubation (Figure 1B) . For all coatings, PAMAM was used as the base layer (Figure 1) . In this study, PAMAM dendrimer (generation 5) was used, whereby 15 % of primary amino end groups on PAMAM was functionalized with MDT 40 . To explore the contribution of net charge on layer formation, a subset of the remaining primary amino groups on the PAMAM-MDT was subsequently modified with glutaric anhydride (GA). GA functionalization was varied from 0 to 20 to 40%, designated as PAMAM 15/0, PAMAM 15/20, and PAMAM 15/40, respectively, resulting in a net dendrimer surface charge of +110 to +51 to -3, as previously published (see Table 1 for summary) 40 . For interim layers, hyperbranched alginate azide, termed alginate-hN 3 , was employed ( Figure 1B) . As previously described, a carbodiimide-based coupling protocol was utilized to hypergraft branched polymeric chains of 3,5-dicarboxyphenylglycineamide onto the alginate backbone, which were subsequently functionalized with azide via treatment with a linear, heterobifunctional poly(ethylene glycol), expressing a primary amino and an azido end group 40 . The molecular weight of the PEG-N 3 linker, and hence the length of the hyperbranched azide functionalized arm, could be modified to explore its impact on the resulting coating. Molecular weights of 300 and 600 g/mol were investigated in this study. The use of hyperbranched and dendrimer polymers, with increased presentation of reactive groups, was found to enhance the efficiency and competency of covalent layerby-layer formation on idealized planar surfaces 40 .
Resulting coatings were visualized with confocal microscopy via FITC labeling of the hyperbranched alginate azide. As illustrated in Figure 1C , nanoscale coatings were generated on alginate microbeads, with coating uniformity and intensity increasing with subsequent layers. Increased net positive charge of the PAMAM correlated with increased uniformity at 2 and 4 layers; however, by 6 layers, coatings generated by any of the PAMAM forms were comparable, with uniform and complete coatings observed. Surprisingly, the presence of azide groups on the base alginate microbead did not significantly impact PAMAM deposition. Resulting coatings were highly stable, even after several weeks of storage at room temperature. 
Stability of coatings following liquification of inner alginate core
Of interest to the generation of a versatile coating platform is the impact of the coatings on bead stability. To explore the contribution of the coatings to enhance alginate stability, alginate or alginate-N 3 microbeads were chelated via EDTA following layer-by-layer coating to remove barium ions and liquefy the inner alginate hydrogel, resulting in alginate microcapsules. The stability of microcapsules was assessed via percent swelling following chelation. For comparison, standard alginate/poly-l-lysine (PLL) coated microbeads were also evaluated. If coatings were not complete or stable, liquification of the inner alginate core would result in ruptured or dissolved beads. Following chelation, a significant increase in the magnitude of swelling was observed, when comparing alginate microcapsules to alginate-N 3 microcapsules, regardless of the coating type (see Table 2 ). The degree of swelling for alginate-N 3 capsules ranged from -2 to 32%, while standard alginate capsules ranged from 30 -44%.
This observed increase in swelling for standard alginate capsules is similar to that reported in studies evaluating PLL coatings. 49 Coated alginate-N 3 microcapsules were reasonably stable following chelation, with minimal breakage observed with handling; however, coated alginate microcapsules were fragile and susceptible to breakage, similar to published reports for standard PLL coatings. 50, 51 This increased fragility of the standard alginate microcapsules is likely attributed to the high degree of swelling following chelation, resulting in mechanically stressed coatings. The significant decrease in swelling for alginate-N 3 versus alginate microbeads is postulated to be due to changes in the alginate chain properties due to the functionalization of the carboxyl groups with PEG-N 3 . The 11% functionalization of the alginate to form alginate-N 3 has been found to result in less compact beads following gelation, likely due to the interference of the PEG-N 3 in the formation of the classic "eggbox" interactions between alginate chains and the gelation cations to form rod-like cross-linked complex. 41 Hence, the less dense gelation network of the alginate-N 3 microbead experiences less swelling following chelation and subsequent liquification, than standard alginate microbeads. Further, the functionalization of the carboxyl groups with PEG-N 3 decreases the net anionic charge of the alginate. While the exact decrease in net anionic charge cannot be measured, given this is highly dependent on the exact monomer groups of the alginate and the pH, it can be concluded that 11% functionalization of the carboxylate groups with neutral PEG-N 3 would result in a subsequent reduction in charge, which would lead to decreased electrostatic repulsion for alginate-N 3 chains, when compared to standard alginate. Overall, the decreased gel compactness and electrostatic repulsion of alginate-N 3 chains likely contributes to the decreased overall swelling of these microcapsules following liquification of the inner alginate core.
Evaluation of the contribution of the layer-by-layer coating on the degree of swelling found significant variation within most groups ( Table 2) . For coatings on alginate-N 3 microcapsules, control PLL/Alg coated beads exhibited no swelling, while swelling for PAMAM/alginate-hN 3 Increasing the layer number from 6 to 12 total layers resulted in enhanced stability of the microbeads, as a significant decrease in swelling was observed for all groups. Increasing the length of the azido-functionalized PEG linker (300 to 600 g/mol) on alginate-hN 3 resulted in a 2-fold increase in % swelling; demonstrating than varying the layer spacing of the PAMAM/alginate-hN 3 coatings impacts their capacity to remodel under osmotic stress.
Overall, these studies demonstrate the stability of covalent layer-by-layer coatings formed using alternating PAMAM/alginate-hN 3 layers, even following substantial swelling of the base coating material. Further, the stability of the coating can be modulated by layer number and spacing. 
Permselectivity of resulting coatings on microcapsules
Modulation of the permselectivity is a critical parameter in the application of biomaterials for drug delivery or cellular encapsulation. To evaluate the capacity of the layer-by-layer coating to impart permselectivity, the inner hydrogel core of the coated microbeads was chelated. This provides a means to delineate the contribution of the base alginate hydrogel on permselectivity. Coated microcapsules were then incubated within FITC-dextran solutions of variable molecular weights (i.e. 4 x 10 3 -2,000 x 10 3 g/mol). PAMAM within the coating was labeled via addition of ethidium homodimer-1 to permit clear identification of the capsule periphery (Figure 2A-D) . 40 Image analysis characterized the degree of infiltration of FITC-dextran, compared to background, to quantify the % permeability. Size exclusion was established when the measured % permeability was less than 10%. As summarized in Figures 2E-F , coated capsules exhibited variations in degree of permselectivity, according to the PAMAM derivative used for the coating and the microcapsule base employed (i.e. alginate-N 3 (Figure 2E) or alginate (Figure 2E) ). Coatings using PAMAM 15/0 and PAMAM 15/20 exhibited the highest permselectivity, where dextrans of MW ≥ 40x10 3 were excluded, regardless of the base microcapsule material. PAMAM 15/40 coatings on alginate-N 3 capsules demonstrated increased permeability to larger dextrans, with MW as high as 250
x 10 3 g/mol, permitted within the capsule, while PAMAM 15/40 coatings on standard alginate capsules were more restrictive (< 70 x 10 3 g/mol). Table 3 summarizes the overall permselectivity of the coatings, correlating this to size range exclusion using the theoretical relationship between dextran molecular weight and its hydrodynamic radius. 45 In general, PAMAM/alginate-hN 3 coatings fabricated using PAMAM 15/0 or 15/20 were more permselective than coatings formed using PAMAM 15/40, regardless of the base capsule material. In comparison to PLL/alginate coated microcapsules, covalent layer-by-layer coatings formed using PAMAM/alginate-hN 3 were generally more permselective, with PLL/Alg coatings on standard alginate restricting dextrans of MW > 70x10 3 g/mol and PLL/Alg coatings on alginate-N 3 restricting dextrans of MW > 2,000x10 3 g/mol (full permeability results for standard PLL/alginate coatings are summarized in Supplementary Materials). To further investigate the adaptable nature of these covalently linked coatings, we explored the contribution of: 1) the number of total layers (Figure 3A) ; 2) the length of the PEG linker used to link azide onto the hyperbranched alginate ( Figure 3B) ; and 3) the base alginate microcapsule material (Figure 3C ) on coating permselectivity. For these studies, covalent layer-by-layer coatings were formed using PAMAM 15/40. As expected, an increase in the number of layers from 6 to 12 resulted in a more restrictive capsule (Figure 3A) , with a significant decrease in migration of the dextran into the capsule between 10 x 10 3 ≤ MW ≤ 250 x 10 3 , although the exclusion cutoff remained the same at 500x10 3 g/mol (R h = 17.2 nm). Increasing the length of the PEG-N 3 linker on the alginate-hN 3 (Figure 3B ) also resulted in modulation of permselectivity, whereby increased migration of dextran was observed when MW ≤ 250 x 10 3 . This increased permselectivity is likely due to the increased thickness of the coatings, generated by the longer azide linker on the alginate-hN 3 . The type of alginate used to form the inner capsule also resulted in modulation of permselectivity (Figure 3C) . Coatings assembled onto standard alginate microcapsules resulted in a significantly higher permselectivity, i.e. MWCO of 70x10 3 for alginate, compared to the 500x10 3 g/mol found for coatings on alginate-N 3 base materials (see Table 3 ). This result was initially unexpected, given the prediction that PAMAM/alginate-hN 3 coatings would be more stable on alginate-N 3 microbeads, given the increased opportunity for covalent bond linkage to the base microbead. Since
Surface imaging of coatings on alginate microbeads versus microcapsules
We postulated that the increase in permselectivity for alginate capsules coated with layers that used PAMAM 15/40 or PLL, when compared to alginate-N 3 capsules coated with the same polymers, could be due to the increased swelling of the inner alginate microbead following chelation. As summarized in Table 2 Materials) . These results do not provide definitive correlations between coating structure and permselectivity, but provides the basis for the focus of future studies.
nonlinear, charged proteins (such as insulin) has been well documented. With this objective, MIN6 cells, a beta cell line, were encapsulated within standard alginate microbeads, followed by the generation of 6 layers of PAMAM/alginate-hN 3 coatings using PAMAM 15/0, PAMAM 15/20, and PAMAM 15/40. Cytotoxicity of the procedure was evaluated via live/dead confocal imaging. As illustrated in Figure 5A , no substantial variation in beta cell viability was observed for PAMAM/alginate-hN 3 coated capsules, particularly when compared to alginate/PLL capsules, although it could be interpreted that PAMAM 15/0 coated beads exhibited a slightly higher degree of peripheral cell death. High cytocompatibility of these coatings was expected, given our published report on the general cytocompatibility of these PAMAM/alginate-hN 3 layers when coated directly onto a pancreatic islet 40 ; however, for coatings formed using PAMAM 15/0, a modest decrease in pancreatic islet viability was noted, which may correlate to the trend observed herein. The ability of insulin, released by the entrapped beta cells, to permeate out of the coated capsules was also assessed and compared to PLL/Alg controls (Figure 5B) .
Insulin release was significantly lower for PAMAM 15/0 coatings, when compared to PLL coated capsules, while other tested coatings were comparable. This decrease could be due to a decreased number of viable cells within the capsule or an increased restriction in insulin diffusion from the coating. Decreased cell viability cannot be ruled out, since a modest increase in dead cells could be interpreted in the live/dead imaging. With respect to insulin diffusion from the coating, permeability testing for alginate coated microcapsules found a significant decrease in coating permeability between 4x10 3 and 10x10 3 g/mol dextrans for coatings assembled using PAMAM 15/0, indicating that decreased diffusion of agents within that molecular weight range, such as insulin (MW 5.8x10 3 g/mol), may be observed. Further, the charge of PAMAM 15/0 is highly cationic (+110), which may contribute to delayed diffusion of the slightly anioic insulin. Overall, these results demonstrate the capacity of insulin to be released from these coatings; although coatings generated using PAMAM 15/0 may impart a delay in insulin migration out of the capsule and thus might not be as suitable as other PAMAM derivatives for this particular application. 
Biocompatibility of PAMAM/alginate coating
The biocompatibility of the PAMAM/alginate is a critical parameter in establishing the relevance of these coatings for in vivo translation. To explore their compatibility, alginate microbeads coated with PAMAM/alginate-hN 3 layers generated using PAMAM 15/0 were used. With the well documented challenges of cations with biocompatibility, 28, 52, 53 we selected coatings formed using PAMAM 15/0, as this was most likely candidate to instigate an undesirable foreign body response. Alginate microbeads were coated with either 6 layers of PAMAM/alginate or 7 layers of PAMAM/alginate, to evaluate of the impact of the surface polymer, i.e. PAMAM 15/0 or hyperbranched alginate-N 3 , on the host response. Uncoated alginate microbeads were used as controls.
As exhibited in Figure 6 , a significant foreign body response to the capsules was not observed after 21 d in vivo. In general, the host response to all capsules was modest, with no deposition of cells on most capsules and only a few atypical microbeads with 1-3 layer thick cellular coatings. In general, a foreign body response is most aggressive within the first 30 days of transplant. 54, 55 As such, this study exhibits high biocompatibility of PAMAM/alginate coated capsules, with minimal foreign body responses when transplanted within the peritoneal site. Future studies will expand assessments to additional formations and transplant sites, with and without encapsulated cells. 
